INTERNATIONAL PATENT: NEC LABORATORIES EUROPE GMBH FILES APPLICATION FOR "PERSONALIZED CANCER VACCINE COMPOSITION WITH ENHANCED CLONAL COVERAGE"

GENEVA, Feb. 2 -- NEC LABORATORIES EUROPE GMBH (Kurfuersten-Anlage 3669115 Heidelberg) filed a patent application (PCT/IB2025/052664) for "PERSONALIZED CANCER VACCINE COMPOSITION WITH ENHANCED CLONAL COVERAGE" on Mar 13, 2025. With publication no. WO/2026/022525, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MOESCH, Anja (c/o NEC Laboratories Europe GmbHKurfuersten-Anlage 3669115 Heidelberg), EGGERT MARTINEZ, Mariana (c/o NEC Laboratories Europe GmbHKurfuersten-Anlage 3669115 Heidelberg), LEPRI, Marco (c/o NEC Laborator...